The SELECT-ACS Trial Effects of the P-selectin antagonist inclacumab on myocardial damage after PCI for NSTEMI Effects of the P-selectin antagonist inclacumab.
P-glycoprotein Associates With Anxa2 and Promotes Invasion in Multidrug Resistant Breast Cancer Cells
Function of CDK9 in cardiac hypertrophy 14 th June 2010.
Phospho-Proteomic Analysis of Signaling Networks Governing Cell Functions
The SELECT-ACS Trial